Erratum
Publish Ahead of Print
The articles on this page have been copyedited and reviewed and approved by the authors. They have not yet been scheduled for a specific issue. For published content, please visit Archive.
Editorial Commentary | Emerging Therapeutics
Expanding therapeutic options for Pompe disease: a new small molecule inhibitor of glycogen synthase 1 (GYS1) shows preclinical promise in Pompe disease
Editorial | Data-Driven Clinical Practice and Policy Making
Articles’ retraction during the pandemic: COVID-19 is not the pacemaker
Editorial Commentary | Clinical Studies
Insulin-producing cells derived from expandable stem cell-derived endoderm are effective for the treatment of type 2 diabetes
Editorial Commentary | Basic and Mechanism Sciences
C9orf72 role in myeloid cells: new perspectives in the investigation of the neuro-immune crosstalk in amyotrophic lateral sclerosis and frontotemporal dementia
Editorial | Data-Driven Clinical Practice and Policy Making